Clarithromycin EP Impurity B
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

299409-85-1Clarithromycin EP Impurity B

● In Stock

Catalogue No.:VE009557
CAS No.:299409-85-1
Mol. Formula:C37H67NO13
Mol. Weight:733.93 g/mol

Additional information on CAS 299409-85-1

Parent drug

Clarithromycin

IUPAC Name

(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-(((2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-12, 13-dihydroxy-4-(((2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3, 5, 7, 9, 11, 13, 14-heptamethyloxacyclotetradecane-2, 10-dione

Synonyms

6-O-Methyl-15-norerythromycin A

Description

Clarithromycin EP Impurity B (CAS No: 299409-85-1) Or (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13,14-heptamethyloxacyclotetradecane-2,10-dione,It is an impurity of Clarithromycin, is a macrolide antibiotic and a semisynthetic macrolide antibiotic, that is used to treat bacterial infections pharyngitis, tonsillitis, respiratory tract infections. it has a semisynthetic macrolide antibiotic. it has 70% protein bound and is well-absorbed, acid stable.

References

Kanatani, M. S., & Guglielmo, B. J. (1994). The new macrolides. Azithromycin and clarithromycin. The Western Journal of Medicine, 160(1), 31–37. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1022251/

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url